Fujita Academy and Rohto Pharmaceutical Co., Ltd. establish a joint venture and enter the real world data business.
May 10, 2023
Rohto Pharmaceutical Co., Ltd. (Osaka City, Osaka Prefecture, President:
Masashi Sugimoto) has established a business company that promotes the
utilization of real-world data with Fujita Innovation Capital Co., Ltd.,
which is wholly owned subsidiary of Fujita academy (Toyoake City, Aichi
Prefecture, Chairman: Kiyotaka Hoshinaga), that manages universities and
university hospitals. Real world data is a general term for medical data
obtained in daily clinical practice, and is a medical big data which is
a collection of information based on medical practices such as receipt
data, ectronic medical record data, health examination, and patient registry
data. Both companies will start a new business in the health, medical,
and nursing care fields for future social implementation and will promote
the utilization of data by providing platform construction, survice design,
data analysis, and development consulting services as well as striving
for strict security and protection of personal information.
Our company's thoughts towards establishment
Our company has set the group's comprehensive management vision for 2030 as "Connect for Well-being," and we are implementing various initiatives in the fields of health, presymptomatic disease, and treatment so that every person can live an active life in body and mind. In recent years, real-world data has attracted increasing attention in the healthcare field, and it has already begun to be widely used in product and service development overseas. AI-based analysis on Japan's medical performance and derived (produced) medical big data will contribute to evaluate safety and effectiveness more quickly and efficiently than
conventional development processes, and these This will truly change the way product development is done.
About our company
| Name |
FirstReal Healthdata Systems Co., Ltd. |
| Address |
2F, Ginza East Building, Ginza 7-16-14, Chuo-ku, Tokyo |
| Establishment date |
April 28, 2023 |
| President |
Yukio Yuzawa (President of Fujita Health University) |
| Shareholders |
Fujita Innovation Capital Co., Ltd., Rohto Pharmaceutical Co., Ltd. |
| Capital |
capital: 100 million yen, capital reserve: 100 million yen |
| Business details |
- PHR (Personal Health Record) utilization project
- Hospital-side projects (projects that contribute to the entire medical
field, such as improving the efficiency of clinical trials, improving the
quality of medical care, regional collaboration projects, in-hospital case
research projects, and improving the health of hospital management)
- Collaborative projects with other service providers (pharmaceuticals, food,
medical equipment)
|
Future outlook
The impact of this matter on our consolidated business results for the
fiscal year ending March 2023 is minimal, and we will promptly notify you
if any matters that need to be announced arise in the future.
About Fujita Gakuen Educational Corporation
| Chairman |
Kiyotaka Hoshinaga |
| Address |
1-98 Dengakugakubo, Kutsukake-cho, Toyoake City, Aichi |
|
Based on the Fundamental Law on Education, the School Education Law, and
the Private School Law, we have established a university with the purpose
of developing human resources who will contribute to academic and social
development through education, research, and medical training related to
medicine, medical care, and health. |
| URL |
https://academy.fujita-hu.ac.jp/ |